Vitamin D3 Supplementation Regimens and Preeclampsia Risk
Recruiting
N/A
Interventional Study
Preeclampsia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 40
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 268 (estimated)
- Sponsor
- Sana'a University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a randomized controlled trial with two parallel groups connected at Al-Thawra Modern General Hospital in Sana'a, Yemen.
It aims to compara the effect of two different vitamin D3 supplementation regimens during pregnancy on the risk of pre-eclampsia among women with confirmed vitamin D deficiency.
Pregnant women attending antenatal care and diagnosed with vitamin D deficiency will b…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Singleton pregnancy
* Pregnant women between 8 and 18 weeks of gestation
* Serum 25-hydroxyvitamin D \[25(OH)D\] level \< 25 ng/mL
* Willing and able to provide written informed consent
* Planning to receive ongoing antenatal care and deliver at Al-Thawra Modern General Hospit…
Contacts